Related Experiment Video
Updated: Dec 3, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Aspergillus-Derived Galactosaminogalactan Triggers Complement Activation on Human Platelets
Hemalata Deshmukh1, Cornelia Speth1,2, Donald C Sheppard3
1Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Abstract:
Invasive fungal infections caused by Aspergillus (A.) and Mucorales species still represent life-threatening diseases in immunocompromised individuals, and deeper knowledge about fungal interactions with elements of innate immunity, such as complement and platelets, appears essential for optimized therapy. Previous studies showed that galactosaminogalactan secreted by A. fumigatus and A. flavus is deposited on platelets, thereby inducing their activation. Since the altered platelet surface is a putative trigger for complement activation, we aimed to study the interplay of platelets with complement in the presence of fungal GAG. Culture supernatants (SN) of A. fumigatus and A. flavus both induced not only GAG deposition but also subsequent deposition of complement C3 fragments on the platelet surface. The SN of a Δuge3 mutant of A. fumigatus, which is unable to synthesize GAG, did not induce complement deposition on platelets, nor did the SN of other Aspergillus species and all tested Mucorales. Detailed analysis revealed that GAG deposition itself triggered the complement cascade rather than the GAG-induced phosphatidylserine exposure. The lectin pathway of complement could be shown to be crucially involved in this process. GAG-induced complement activation on the platelet surface was revealed to trigger processes that might contribute to the pathogenesis of invasive aspergillosis by A. fumigatus or A. flavus. Both pro-inflammatory anaphylatoxins C3a and C5a arose when platelets were incubated with SN of these fungal species; these processes might favor excessive inflammation after fungal infection. Furthermore, platelets were stimulated to shed microparticles, which are also known to harbor pro-inflammatory and pro-coagulant properties. Not only did early processes of the complement cascade proceed on platelets, but also the formation of the terminal complement C5b-9 complex was detected on platelets after incubation with fungal SN. Subsequently, reduced viability of the platelets could be shown, which might contribute to the lowered platelet numbers found in infected patients. In summary, fungal GAG initiates an interplay between complement and platelets that can be supposed to contribute to excessive inflammation, thrombocytopenia, and thrombosis, which are important hallmarks of fatal invasive mycoses.
Insights
Invasive fungal infections involve interactions between fungal galactosaminogalactan (GAG) and platelets, activating complement. This interplay contributes to inflammation and low platelet counts in patients with invasive aspergillosis.
Area of Science:
- Mycology
- Immunology
- Hematology
Background:
- Invasive fungal infections by Aspergillus and Mucorales species are life-threatening in immunocompromised individuals.
- Understanding fungal interactions with innate immunity, like complement and platelets, is crucial for effective therapy.
- Galactosaminogalactan (GAG) secreted by Aspergillus species deposits on platelets, inducing activation.
Purpose of the Study:
- To investigate the interplay between platelets and complement in the presence of fungal GAG.
- To determine if GAG deposition on platelets triggers complement activation.
- To elucidate the role of this interaction in the pathogenesis of invasive aspergillosis.
Main Methods:
- Incubation of human platelets with culture supernatants from Aspergillus fumigatus and Aspergillus flavus.
- Analysis of GAG and complement C3 fragment deposition on platelets using immunofluorescence.
- Assessment of complement activation pathways, including the lectin pathway.
- Measurement of pro-inflammatory anaphylatoxins (C3a, C5a) and microparticle shedding.
- Evaluation of platelet viability and terminal complement complex (C5b-9) formation.
Main Results:
- Culture supernatants containing GAG induced deposition of complement C3 fragments on platelets.
- A mutant lacking GAG synthesis did not induce complement deposition, confirming GAG's role.
- GAG deposition directly triggered complement cascade activation via the lectin pathway.
- GAG-induced complement activation led to the release of pro-inflammatory anaphylatoxins (C3a, C5a) and platelet microparticles.
- Terminal complement complex (C5b-9) formed on platelets, correlating with reduced platelet viability.
Conclusions:
- Fungal GAG initiates a significant interplay between complement and platelets.
- This interaction promotes excessive inflammation, thrombocytopenia, and thrombosis in invasive aspergillosis.
- Targeting GAG-platelet-complement interactions may offer novel therapeutic strategies for invasive fungal infections.
More Related Videos
04:32A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Complement System
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Proteoglycans
GPCRs Regulate Adenylyl Cylase Activity
Intracellular Signaling Affects Focal Adhesions
Some...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...